Literature DB >> 19948768

Mature and functional viral miRNAs transcribed from novel RNA polymerase III promoters.

Kevin W Diebel1, Anna L Smith, Linda F van Dyk.   

Abstract

Murid herpesvirus 4 (MuHV-4) microRNAs were previously cloned from latently infected tumor cells and predicted to be processed from a series of RNA polymerase III primary transcripts. We detected maturely processed MuHV-4 miRNAs within total RNA from lytically infected cells in vitro and infected tissues ex vivo, using a highly sensitive reverse ligation meditated RT-PCR strategy. We determined that the MuHV-4 microRNAs are biologically active during infection by a luciferase reporter system. We experimentally demonstrated that transcription of the MuHV-4 microRNAs is by RNA polymerase III by alpha-amanitin insensitivity and by specific deletion of the RNA polymerase III type 2-like promoter elements of MuHV-4, resulting in the complete loss of miRNA detection and function. Finally, we demonstrate that these 10 viral miRNAs, each transcribed from highly conserved and novel polymerase III promoter elements, vary markedly in their relative abundance and activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948768      PMCID: PMC2802027          DOI: 10.1261/rna.1873910

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  55 in total

1.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

Review 4.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 5.  Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis.

Authors:  J P Simas; S Efstathiou
Journal:  Trends Microbiol       Date:  1998-07       Impact factor: 17.079

6.  Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency.

Authors:  R J Bowden; J P Simas; A J Davis; S Efstathiou
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

7.  Joining of RNA molecules with RNA ligase.

Authors:  P J Romaniuk; O C Uhlenbeck
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice.

Authors:  E J Usherwood; J P Stewart; A A Nash
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure.

Authors:  David H Mathews; Matthew D Disney; Jessica L Childs; Susan J Schroeder; Michael Zuker; Douglas H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

10.  Identification of a region of the virus genome involved in murine gammaherpesvirus 68-induced splenic pathology.

Authors:  Bernadette M Dutia; Douglas J Roy; Bahram Ebrahimi; Babunilayam Gangadharan; Stacey Efstathiou; James P Stewart; Anthony A Nash
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

View more
  52 in total

Review 1.  Diverse virus-host interactions influence RNA-based regulation during γ-herpesvirus infection.

Authors:  Lisa M Kronstad; Britt A Glaunsinger
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

2.  Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts.

Authors:  Tiffany A Reese; Jing Xia; L Steven Johnson; Xiang Zhou; Weixiong Zhang; Herbert W Virgin
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

3.  Gammaherpesvirus 68 infection of endothelial cells requires both host autophagy genes and viral oncogenes for optimal survival and persistence.

Authors:  Andrea Luísa Suárez; Raymond Kong; Tad George; Liqiang He; Zhenyu Yue; Linda Faye van Dyk
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 4.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 5.  Versatile microRNA biogenesis in animals and their viruses.

Authors:  Mingyi Xie; Joan A Steitz
Journal:  RNA Biol       Date:  2014-05-07       Impact factor: 4.652

6.  Redefining the genetics of murine gammaherpesvirus 68 via transcriptome-based annotation.

Authors:  L Steven Johnson; Erin K Willert; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2010-06-25       Impact factor: 21.023

Review 7.  Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis.

Authors:  Whitney L Bullard; Erik K Flemington; Rolf Renne; Scott A Tibbetts
Journal:  Trends Cancer       Date:  2018-10-10

8.  Poly(A) at the 3' end of positive-strand RNA and VPg-linked poly(U) at the 5' end of negative-strand RNA are reciprocal templates during replication of poliovirus RNA.

Authors:  Benjamin P Steil; Brian J Kempf; David J Barton
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

Review 9.  Complexities of gammaherpesvirus transcription revealed by microarrays and RNAseq.

Authors:  Laurie T Krug
Journal:  Curr Opin Virol       Date:  2013-05-16       Impact factor: 7.090

10.  A conserved RNA polymerase III promoter required for gammaherpesvirus TMER transcription and microRNA processing.

Authors:  Kevin W Diebel; David J Claypool; Linda F van Dyk
Journal:  Gene       Date:  2014-04-16       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.